T cell mediated allergy to abciximab.
Moneret-Vautrin
D A
DA
Department of Internal Medicine, Clinical Immunology and Allergology, Hôpital Central, 29 avenue de Lattre de Tassigny, 54035 Nancy Cedex, France. s.barrat@chu-nancy.fr
Morisset
M
M
Vignaud
J M
JM
Kanny
G
G
D000077284:Abciximab; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D004802:Eosinophilia / Q000139:chemically induced; D005260:Female; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000009:adverse effects*; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D013601:T-Lymphocytes / Q000276:immunology*
D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D000077284:Abciximab